mfresearch ๐Ÿ”’ Show amounts

Sundaram Focused Fund (Formerly Known as Principal Focused Multicap Fund) - Direct Plan - GROWTH

code 149533 Focused Fund direct plan ยท growth NAVs 2022-01-03 to 2026-11-09

Benchmark: NIFTY 500 official TRI declared: AMFI Fund Performance (Fund-Performance-30-Sep-2026--2031 (9).xlsx), as of 2026-09-30 Compare with:

Growth of โ‚น10,000 vs benchmark

From 2022-01-03, common dates. Scroll or drag to zoom.

Drawdown

Rolling 3-year CAGR

Returns

periodfundfund*benchmark*fund โˆ’ benchmark*from โ†’ to
1M5.04% -5.15%-6.04% 0.89% 2026-10-09 โ†’ 2026-11-09
3M-1.38% -0.10%-3.61% 3.51% 2026-08-07 โ†’ 2026-11-09
6M6.01% 10.67%5.81% 4.86% 2026-05-08 โ†’ 2026-11-09
1Y4.03% 2.57%-1.79% 4.37% 2025-11-07 โ†’ 2026-11-09
3Y11.22% 9.71%9.55% 0.16% 2023-11-09 โ†’ 2026-11-09
5Y- -- -
7Y- -- -
10Y- -- -
since inception9.53% 8.97%9.31% -0.35% 2022-01-03 โ†’ 2026-11-09

Absolute under 1 year, CAGR from 1 year. * Common dates only.

Calendar years

year202320242025
fund25.71%18.46%3.02%
benchmark26.91%16.24%7.76%

Rolling returns

lengthperiodsaveragemedianworstbest% positive% beating benchmark
1 year91713.33%8.47% -7.52%41.47%84% 31%
3 years42714.10%13.91% 9.17%21.15%100% 1%

Risk and risk-adjusted return

3 years
2023-11 โ€“ 2026-10
CAGR10.40%
volatility13.30%
max drawdown-17.17%
downside deviation9.45%
Sharpe ratio0.37
Sortino ratio0.52
Calmar ratio0.61
alpha (annualised)-
beta-
Rยฒ-
tracking error-
information ratio-
up / down capture-
Treynor ratio-
36 months: benchmark lacks some months of the window: no relative metrics

Category: Focused Fund

Overall โ˜…โ˜…โ˜…โ˜†โ˜† (3y โ˜…โ˜…โ˜…โ˜†โ˜† ยท 5y - ยท 10y -) ยท as of 2026-10 ยท 57 months of history

percentile rank (1 = best)3 years
of 27 funds
return70th
volatility4th
Sharpe66th
Sortino70th
worst fall39th
risk-adjusted return (MRAR)66th

View category โ†’

Ratings: Morningstar method. Differences: risk-free rate: RBI 91-day T-bill (Morningstar uses FBIL MIBOR Overnight for rupee funds); peer groups: SEBI-category groups (D13), not Morningstar Categories; no analyst rating suspensions.

Add to comparison โ†’